4//SEC Filing
Manzano Stephen 4
Accession 0000899243-20-006629
CIK 0001723128other
Filed
Mar 1, 7:00 PM ET
Accepted
Mar 2, 8:13 PM ET
Size
13.2 KB
Accession
0000899243-20-006629
Insider Transaction Report
Form 4
Manzano Stephen
SVP, General Counsel
Transactions
- Award
Performance-Based Restricted Stock Units
2020-02-27+131,926→ 131,926 total→ Class A Common Stock (131,926 underlying) - Award
Restricted Stock Units
2020-02-27+65,963→ 65,963 total→ Class A Common Stock (65,963 underlying)
Footnotes (5)
- [F1]Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.
- [F2]The restricted stock units vest in four equal annual installments beginning on February 27, 2021.
- [F3]Each performance-based restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.
- [F4]Represents the maximum number of shares issuable under the performance-based restricted stock units.
- [F5]25% of the performance-based restricted stock units are earned and eligible to vest upon the Issuer's Class A Common Stock achieving an average closing price per share of $8 or higher for 60 consecutive calendar days during the three-year performance period. An additional 12.5% of the performance-based restricted stock units are earned and eligible to vest upon the Issuer's Class A Common Stock achieving an average closing price per share of $10, $12, $14, $16, $18 and $20, respectively, for 60 consecutive calendar days during the three-year performance period. For average 60-day closing stock prices between $12 and $20 per share, the number of performance-based restricted stock units that become earned will be determined using straight line interpolation. Any earned performance-based restricted stock units vest in full on February 28, 2023, the last day of the performance period.
Issuer
Amneal Pharmaceuticals, Inc.
CIK 0001723128
Entity typeother
Related Parties
1- filerCIK 0001798993
Filing Metadata
- Form type
- 4
- Filed
- Mar 1, 7:00 PM ET
- Accepted
- Mar 2, 8:13 PM ET
- Size
- 13.2 KB